Highlights Selvita S.A.

Equities

SLV

PLSLVCR00029

Market Closed - Warsaw S.E. Other stock markets 11:55:45 2024-05-02 am EDT			5-day change	1st Jan Change
70.6 ^PLN	+1.44%		+5.37%	+20.68%

Mar. 28	Selvita S.A. agreed to acquire PozLab sp. z o.o.	CI
Mar. 27	Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Selvita S.A. agreed to acquire PozLab sp. z o.o.	Mar. 27	CI
Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Selvita S.A. Launches Biologic Drug Discovery and Development Services	Mar. 18	CI
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-27	CI
The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease	23-06-05	CI
Selvita S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Selvita S.A. Continues to Scale its Operations with the Completion of New Research Centre	23-03-27	CI
Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-14	CI
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-16	CI
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-16	CI
Selvita S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Immagene B.V. and Selvita Announce Integrated Drug Discovery Cooperation	22-02-07	CI
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-24	CI
Selvita S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-09-22	CI
Selvita Scales Its Operations with the Construction of New Research Space	21-07-12	CI
Selvita Reports Earnings Results for the First Quarter 2021	21-05-26	CI
Mabion S A : Big pharma and private equity seek healthy returns in Europe's east	21-05-20	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Selvita S.A.

Equities

SLV

PLSLVCR00029

Highlights

Filters